A Study of MK-8507 and Islatravir (MK-8591) in Healthy Adult Participants (MK-8507-016)
Clinical trial NCT06619678 · COMPLETED
Trial details
- NCT number
- NCT06619678
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-17
- Primary completion
- 2024-06-23
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.